About two million American men undergo transrectal biopsies each year to diagnose prostate cancer or to monitor low-risk and favorable intermediate-risk prostate cancers for active surveillance (AS).

When it comes to prostate biopsy, is the transperineal or transrectal route better? Urologists are currently awaiting results from ongoing clinical trials exploring whether transperineal prostate ...

A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect prostate ...

Prostate ultrasound and biopsy are tests that check the abnormal results of a digital rectal exam or an elevated prostate-specific antigen (PSA) blood test. Prostate ultrasound uses a probe about the ...

In 2018, a 68-year-old Norwegian stonemason named Roar Gulbrandsen died after undergoing a routine transrectal biopsy. When the cause of death was determined to have been a massive, preventable ...

Prostate cancer is the most common cancer in the developed world. The most widely used method of diagnosing prostate cancer involves a biopsy that passes a needle through the lining of the lower bowel ...

Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus ...

Extended analysis of a validated urine-exosome signature to predict high grade prostate cancer on initial biopsy: Performance across multiple sub-groups. This is an ASCO Meeting Abstract from the 2016 ...

If the Crossfire debate at the American Urological Association (AUA) virtual annual meeting is any indication, advocates for transperineal (TP) biopsies face an uphill battle in persuading U.S.